Clinical Trial

Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer

Study acronym: MSIRus22
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 25, 2022 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-08.
Status change: Not Yet Recruiting → Recruiting 2022-10-24
Trial Details
NCT Number NCT05495776
Lead Sponsor State Scientific Centre of Coloproctology, Russian Federation
Collaborators: The Loginov MCSC MHD, Pirogov National Medical and Surgical Center, Moscow City Oncological Hospital No. 62 MHD, City Clinical Oncological Hospital No. 1 MHD, Moscow Multidisciplinary Clinical Center "Kommunarka", D.D. Pletnev City Clinical Hospital MHD, Botkin Hospital MHD, Clinic K+31
Conditions Colorectal Cancer, Lynch Syndrome, Hereditary Colorectal Cancer, MSI
Enrollment 2,500 participants
Start Date 2022-08-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-10-25